Clinical significance of serum carbohydrate antigen 19.9 and duke pancreatic monoclonal antigen type 2 for the prediction of hematogenous metastases in patients with pancreatic ducal adenocarcinoma

Kurahara Hiroshi; Maemura Kosei; Mataki Yuko; Sakoda Masahiko; Iino Satoshi; Arigami Takaaki; Mori Shinichiro; Ueno Shinichi; Shinchi Hiroyuki; Takao Sonshin; Natsugoe Shoji

首页> 外文期刊>Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] >Clinical significance of serum carbohydrate antigen 19.9 and duke pancreatic monoclonal antigen type 2 for the prediction of hematogenous metastases in patients with pancreatic ducal adenocarcinoma

【24h】

Clinical significance of serum carbohydrate antigen 19.9 and duke pancreatic monoclonal antigen type 2 for the prediction of hematogenous metastases in patients with pancreatic ducal adenocarcinoma

机译：血清糖类抗原19.9和2型公爵胰腺单克隆抗原对预测胰腺导管腺癌血源性转移的临床意义

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: The aim of the present study was to investigate the effectiveness of serum carbohydrate antigen (CA) 19.9 and duke pancreatic monoclonal antigen type 2 (DUPAN-2) levels in the prediction of early hematogenous metastases and as indicators of neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma (PDAC).

机译：目的：本研究的目的是研究血清糖蛋白抗原（CA）19.9和公爵胰腺单克隆抗原2型（DUPAN-2）水平在预测早期血源性转移以及作为新辅助治疗指标方面的有效性。胰腺导管腺癌（PDAC）。

著录项

来源
《Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] 》 |2016年第6期| 共6页
作者
Kurahara Hiroshi; Maemura Kosei; Mataki Yuko; Sakoda Masahiko; Iino Satoshi; Arigami Takaaki; Mori Shinichiro; Ueno Shinichi; Shinchi Hiroyuki; Takao Sonshin; Natsugoe Shoji;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病 ;
关键词
Metastasis; Tumor marker; Recurrence; CA 19.9; DUPAN-2;

机译：转移;肿瘤标志物;复发;CA 19.9;DUPAN-2;

相似文献

外文文献
中文文献
专利

1. Clinical significance of serum carbohydrate antigen 19.9 and duke pancreatic monoclonal antigen type 2 for the prediction of hematogenous metastases in patients with pancreatic ducal adenocarcinoma [J] . Kurahara Hiroshi, Maemura Kosei, Mataki Yuko, Pancreatology: official journal of the International Association of Pancreatology (IAP) ... [et al.] . 2016 ,第6期

机译：血清糖类抗原19.9和2型公爵胰腺单克隆抗原对预测胰腺导管腺癌血源性转移的临床意义
2. Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19-9 Is Associated With Recurrence for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma [J] . Nakagawa Shigeki, Yamashita Yo-ichi, Umezaki Naoki, Pancreas . 2018 ,第9期

机译：基于预后营养指数，癌丙烯醛抗原和碳水化合物抗原19-9的血清标记分数与接受胰腺导管腺癌手术的患者的复发相关
3. Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma. [J] . Fujioka S, Misawa T, Okamoto T, Journal of hepato-biliary-pancreatic surgery . 2007 ,第6期

机译：术前血清癌胚抗原和糖类抗原19-9水平用于评估胰腺腺癌患者的可治愈性和可切除性。
4. Texture Analysis For Survival Prediction of Pancreatic Ductal Adenocarcinoma Patients with Neoadjuvant Chemotherapy [C] . Jayasree Chakraborty, Liana Langdon-Embry, Joanna G. Escalon, Conference on imaging processing . 2016

机译：纹理分析对胰腺癌新辅助化疗患者生存率的预测
5. The CA19-9 Antigen and sTRA Glycans Define Independent Pancreatic Ductal Adenocarcinoma Subpopulations Improving Diagnostic Accuracy and Approach to Prognostic Classification [D] . Barnett, Daniel Mark. 2020

机译：Ca19-9抗原和stra聚糖定义独立的胰腺导管腺癌群，提高了预后分类的诊断准确性和方法
6. Decreased serum carbohydrate antigen 19–9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients [O] . Shuichi Aoki, Fuyuhiko Motoi, Yoshiaki Murakami, 2019

机译：新辅助治疗后血清碳水化合物抗原19–9水平降低预示胰腺腺癌患者的预后更好：一项240例患者的多中心病例对照研究
7. A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score. [O] . Pasanen, P. A., Eskelinen, M., Partanen, K., 1994

机译：血清肿瘤标志物癌胚抗原，糖类抗原50和242，组织多肽抗原和组织多肽特异性抗原在胰腺癌诊断中的前瞻性研究，特别涉及多因素诊断评分。

Clinical significance of serum carbohydrate antigen 19.9 and duke pancreatic monoclonal antigen type 2 for the prediction of hematogenous metastases in patients with pancreatic ducal adenocarcinoma

摘要

著录项

相似文献

相关主题

期刊订阅